The rheumatoid arthritis citrullinome is enriched in antigenic complement proteins

类风湿性关节炎瓜氨酸肽组富含抗原性补体蛋白。

阅读:1

Abstract

OBJECTIVES: Citrullination is a post-translational modification that serves as an autoantigen in Rheumatoid Arthritis (RA). It remains unclear whether there is an excess production of specific citrullinated proteins in RA patients that is driving the autoantibody response. The aim of this study was to undertake an unsupervised proteomic analysis of the circulating RA citrullinome, and determine the consequences of citrullination in RA. METHODS: Citrullinated serum proteins were isolated and measured by mass spectrometry from 10 anti-citrullinated protein antibody (ACPA) positive RA patients and 10 controls. Cit-proteins and cit-immune complexes (IC) were measured in a larger cohort of unaffected first-degree relatives (FDR, ACPA- n = 31, ACPA+ n = 26) and RA (n = 31). Autoantibodies to citrullinated C9, and linear peptides of citrullinated C9 were measured. Structural changes imparted by citrullination were studied in-silico using Alphafold 3.0. RESULTS: Differential analysis of the RA citrullinome revealed a higher expression of complement proteins. Validation studies revealed that the levels of cit-C9 (p = 0.02) and cit-CFI (Complement Factor I, p = 0.019) were higher in RA than controls. Cit-C9 IgG, but not cit-CFI, immune complexes were elevated in ACPA+ FDR (p < 0.0001) and RA (p < 0.0001) compared to ACPA- FDR. Autoantibodies to cit-C9 were also higher in ACPA+ FDR (p = 0.01) and RA (p = 0.002). Reactivity to linear peptides of cit/homocit C9 were enriched in RA patients compared to controls. In-silico modelling revealed structural changes to the monomeric and multimeric structure of cit-C9. CONCLUSION: This analysis of the circulating citrullinome in RA reveals the generation of citrullinated complement proteins that serve as autoantigens.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。